secwatch.observer — SEC 8-K summary
======================================

Issuer:     Day One Biopharmaceuticals, Inc. (—)
CIK:        0001845337
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001193125-23-291669
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Day One Biopharma updates Code of Ethics; no waivers granted
------------------------------------------------------------

- Amendments cover conflicts of interest, related party transactions, confidentiality, and reporting violations.
- Added provisions on fair dealing and compliance with healthcare laws.
- No explicit or implicit waivers resulted from the amendments.
- Code applies to all officers, directors, and employees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845337/000119312523291669/0001193125-23-291669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845337/000119312523291669/d636207d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-291669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer